Douglas Pharma Of New Zealand Reported Weighing Acquisition
This article was originally published in PharmAsia News
Executive Summary
New Zealand’s Douglas Pharmaceuticals reportedly has approached a bank to recommend whether the company should put itself up for sale, either entirely or in parts.